289 related articles for article (PubMed ID: 25929666)
41. Monophasic, solitary tumefactive demyelinating lesion: neuroimaging features and neuropathological diagnosis.
Tan HM; Chan LL; Chuah KL; Goh NS; Tang KK
Br J Radiol; 2004 Feb; 77(914):153-6. PubMed ID: 15010391
[TBL] [Abstract][Full Text] [Related]
42. Balo's concentric sclerosis: An atypical demyelinating disease in pediatrics.
Arenas Vargas LE; Bedoya Morales AM; Rincón Carreño C; Espitia Segura OM; Penagos N
Mult Scler Relat Disord; 2020 Sep; 44():102198. PubMed ID: 32531753
[TBL] [Abstract][Full Text] [Related]
43. Frontal Tumefactive Demyelinating Lesion Mimicking Glioblastoma Differentiated by Methionine Positron Emission Tomography.
Yasuda S; Yano H; Kimura A; Suzui N; Nakayama N; Shinoda J; Iwama T
World Neurosurg; 2018 Nov; 119():244-248. PubMed ID: 30114544
[TBL] [Abstract][Full Text] [Related]
44. Characterization of tumefactive demyelinating lesions using MR imaging and in-vivo proton MR spectroscopy.
Malhotra HS; Jain KK; Agarwal A; Singh MK; Yadav SK; Husain M; Krishnani N; Gupta RK
Mult Scler; 2009 Feb; 15(2):193-203. PubMed ID: 19181773
[TBL] [Abstract][Full Text] [Related]
45. Clinical and radiological characteristics and outcomes of patients with recurrent or relapsing tumefactive demyelination.
Pervin I; Ramanathan S; Cappelen-Smith C; Vucic S; Reddel SW; Hardy TA
Mult Scler Relat Disord; 2024 Feb; 82():105408. PubMed ID: 38219394
[TBL] [Abstract][Full Text] [Related]
46. Neuro-oncology dilemma: Tumour or tumefactive demyelinating lesion.
Abdoli M; Freedman MS
Mult Scler Relat Disord; 2015 Nov; 4(6):555-66. PubMed ID: 26590662
[TBL] [Abstract][Full Text] [Related]
47. Heterogeneity of Baló's concentric sclerosis: a study of eight cases with different therapeutic concepts.
Tzanetakos D; Vakrakou AG; Tzartos JS; Velonakis G; Evangelopoulos ME; Anagnostouli M; Koutsis G; Dardiotis E; Karavasilis E; Toulas P; Stefanis L; Kilidireas C
BMC Neurol; 2020 Nov; 20(1):400. PubMed ID: 33138795
[TBL] [Abstract][Full Text] [Related]
48. Progressive solitary sclerosis: Gradual motor impairment from a single CNS demyelinating lesion.
Keegan BM; Kaufmann TJ; Weinshenker BG; Kantarci OH; Schmalstieg WF; Paz Soldan MM; Flanagan EP
Neurology; 2016 Oct; 87(16):1713-1719. PubMed ID: 27638926
[TBL] [Abstract][Full Text] [Related]
49. Serial MRI studies in pathologically verified Balò's concentric sclerosis.
Chen CJ; Ro LS; Chang CN; Ho YS; Lu CS
J Comput Assist Tomogr; 1996; 20(5):732-5. PubMed ID: 8797902
[TBL] [Abstract][Full Text] [Related]
50. Inaugural tumor-like multiple sclerosis: clinical presentation and medium-term outcome in 87 patients.
Balloy G; Pelletier J; Suchet L; Lebrun C; Cohen M; Vermersch P; Zephir H; Duhin E; Gout O; Deschamps R; Le Page E; Edan G; Labauge P; Carra-Dallieres C; Rumbach L; Berger E; Lejeune P; Devos P; N'Kendjuo JB; Coustans M; Auffray-Calvier E; Daumas-Duport B; Michel L; Lefrere F; Laplaud DA; Brosset C; Derkinderen P; de Seze J; Wiertlewski S;
J Neurol; 2018 Oct; 265(10):2251-2259. PubMed ID: 30054790
[TBL] [Abstract][Full Text] [Related]
51. Clinical and radiographic spectrum of pathologically confirmed tumefactive multiple sclerosis.
Lucchinetti CF; Gavrilova RH; Metz I; Parisi JE; Scheithauer BW; Weigand S; Thomsen K; Mandrekar J; Altintas A; Erickson BJ; König F; Giannini C; Lassmann H; Linbo L; Pittock SJ; Brück W
Brain; 2008 Jul; 131(Pt 7):1759-75. PubMed ID: 18535080
[TBL] [Abstract][Full Text] [Related]
52. Clinical and radiological characteristics of 17 Chinese patients with pathology confirmed tumefactive demyelinating diseases: follow-up study.
Yao J; Huang D; Gui Q; Chen X; Lou X; Wu L; Cheng C; Li J; Wu W
J Neurol Sci; 2015 Jan; 348(1-2):153-9. PubMed ID: 25499757
[TBL] [Abstract][Full Text] [Related]
53. Pediatric tumefactive demyelination: case series and review of the literature.
McAdam LC; Blaser SI; Banwell BL
Pediatr Neurol; 2002 Jan; 26(1):18-25. PubMed ID: 11814730
[TBL] [Abstract][Full Text] [Related]
54. Baló's concentric sclerosis and tumefactive demyelination: a shared immunopathogenesis?
Hardy TA; Beadnall HN; Sutton IJ; Mohamed A; Jonker BP; Buckland ME; Barnett MH
J Neurol Sci; 2015 Jan; 348(1-2):279-81. PubMed ID: 25475150
[TBL] [Abstract][Full Text] [Related]
55. Tumefactive multiple sclerosis versus high-grade glioma: A diagnostic dilemma.
French HD
Surg Neurol Int; 2021; 12():199. PubMed ID: 34084626
[TBL] [Abstract][Full Text] [Related]
56. Evolution and long term outcome in patients presenting with large demyelinating lesions as their first clinical event.
Wattamwar PR; Baheti NN; Kesavadas C; Nair M; Radhakrishnan A
J Neurol Sci; 2010 Oct; 297(1-2):29-35. PubMed ID: 20678779
[TBL] [Abstract][Full Text] [Related]
57. Acute fulminant demyelinating disease: a descriptive study of 60 patients.
de Seze J; Debouverie M; Zephir H; Lebrun C; Blanc F; Bourg V; Wiertlewski S; Pittion S; Laplaud D; Le Page E; Deschamps R; Cabre P; Pelletier J; Malikova I; Clavelou P; Jaillon V; Defer G; Labauge P; Gout O; Boulay C; Edan G; Vermersch P
Arch Neurol; 2007 Oct; 64(10):1426-32. PubMed ID: 17923626
[TBL] [Abstract][Full Text] [Related]
58. Tumefactive Demyelination Lesions: Report on three cases.
Lin CJ; Lin SC; Yu KW; Ou Yang WY; Lee YC; Liao YC
Acta Neurol Taiwan; 2024 Dec; 33(4)():195-200. PubMed ID: 38073158
[TBL] [Abstract][Full Text] [Related]
59. Paraneoplastic tumefactive demyelination with underlying combined germ cell cancer.
Broadfoot JR; Archer HA; Coulthard E; Appelman AP; Sutak J; Braybrooke JP; Love S
Pract Neurol; 2015 Dec; 15(6):451-5. PubMed ID: 26088612
[TBL] [Abstract][Full Text] [Related]
60. Tumefactive demyelination: an unusual cause of a spontaneously resolving homonymous hemianopia.
Dwivedi RA; Dwivedi RE; Durnian JM; Young CA
BMJ Case Rep; 2013 Jun; 2013():. PubMed ID: 23813509
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
